Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board.

Regulator or regulatory shield? The case for reforming Canada's Patented Medicine Prices Review Board. CMAJ. 2017 Apr 10;189(14):E515-E516 Authors: Zhang R, Martin D, Naylor CD PMID: 28396326 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/28396326?dopt=Abstract

Source: cmaj - April 10, 2017 Category: Journals (General) Authors: Zhang R, Martin D, Naylor CD Tags: CMAJ Source Type: research

More News: General Medicine